Crocs (NASDAQ:CROX) PT Raised to $124.00

Crocs (NASDAQ:CROX) had its price objective upped by analysts at UBS Group from $117.00 to $124.00 in a research report issued on Tuesday, Benzinga reports. The brokerage presently has a “neutral” rating on the textile maker’s stock. UBS Group’s price target indicates a potential downside of 2.87% from the company’s previous close.

Several other analysts have also recently issued reports on the company. Bank of America raised their target price on Crocs from $140.00 to $150.00 and gave the stock a “buy” rating in a research note on Wednesday, March 20th. Raymond James raised their price objective on shares of Crocs from $120.00 to $145.00 and gave the stock a “strong-buy” rating in a report on Friday, February 16th. B. Riley raised their price objective on shares of Crocs from $95.00 to $122.00 and gave the stock a “neutral” rating in a report on Wednesday, April 10th. KeyCorp raised their price objective on shares of Crocs from $130.00 to $149.00 and gave the stock an “overweight” rating in a report on Thursday, March 21st. Finally, Stifel Nicolaus raised their price objective on shares of Crocs from $132.00 to $140.00 and gave the stock a “buy” rating in a report on Friday, February 16th. Four research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $145.17.

Crocs Price Performance

Shares of CROX stock traded up $2.29 on Tuesday, reaching $127.67. The company’s stock had a trading volume of 343,175 shares, compared to its average volume of 1,413,808. The company has a quick ratio of 0.75, a current ratio of 1.30 and a debt-to-equity ratio of 1.13. Crocs has a 12-month low of $74.00 and a 12-month high of $151.32. The company has a market capitalization of $7.72 billion, a P/E ratio of 9.95, a PEG ratio of 1.52 and a beta of 2.01. The stock’s 50 day simple moving average is $127.41 and its 200-day simple moving average is $106.64.

Crocs (NASDAQ:CROX) last released its earnings results on Thursday, February 15th. The textile maker reported $2.58 EPS for the quarter, beating analysts’ consensus estimates of $2.38 by $0.20. The business had revenue of $960.10 million for the quarter, compared to analysts’ expectations of $958.39 million. Crocs had a return on equity of 61.97% and a net margin of 20.00%. The firm’s revenue was up 1.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.65 earnings per share. As a group, equities analysts predict that Crocs will post 12.46 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director John B. Replogle bought 1,972 shares of the business’s stock in a transaction on Thursday, March 14th. The stock was acquired at an average price of $126.75 per share, with a total value of $249,951.00. Following the transaction, the director now owns 3,153 shares in the company, valued at approximately $399,642.75. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other Crocs news, President Michelle Poole sold 5,074 shares of Crocs stock in a transaction that occurred on Tuesday, March 12th. The shares were sold at an average price of $124.98, for a total value of $634,148.52. Following the completion of the sale, the president now owns 52,966 shares of the company’s stock, valued at approximately $6,619,690.68. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director John B. Replogle bought 1,972 shares of the business’s stock in a transaction on Thursday, March 14th. The stock was bought at an average cost of $126.75 per share, with a total value of $249,951.00. Following the transaction, the director now owns 3,153 shares in the company, valued at approximately $399,642.75. The disclosure for this purchase can be found here. In the last quarter, insiders sold 39,867 shares of company stock valued at $4,786,276. Company insiders own 2.69% of the company’s stock.

Institutional Investors Weigh In On Crocs

A number of hedge funds have recently modified their holdings of CROX. Rise Advisors LLC purchased a new stake in Crocs in the 1st quarter worth $25,000. Byrne Asset Management LLC grew its holdings in Crocs by 60.0% during the 4th quarter. Byrne Asset Management LLC now owns 320 shares of the textile maker’s stock valued at $30,000 after purchasing an additional 120 shares during the last quarter. Blue Trust Inc. grew its stake in Crocs by 185.0% in the 4th quarter. Blue Trust Inc. now owns 342 shares of the textile maker’s stock worth $32,000 after acquiring an additional 222 shares in the last quarter. Quest Partners LLC bought a new position in Crocs in the 4th quarter worth about $53,000. Finally, Harvest Fund Management Co. Ltd bought a new position in Crocs in the 4th quarter worth about $56,000. Institutional investors own 93.44% of the company’s stock.

About Crocs

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.